Weigh Pros and Cons of Meds for Primary Prevention of Breast Cancer
November 2019
You'll see renewed interest in meds to prevent breast cancer...due to updated U.S. Preventive Services Task Force recommendations.
Use shared decision-making to discuss prevention for women over 35 with other risks, such as atypical hyperplasia or a first-degree relative with breast cancer...or for BRCA mutation carriers who don't want surgery.
Tell women to expect hot flashes with any preventive option. And explain that they'll need to take these meds for 5 years.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote